119 HR 8764 IH: Treatment and Relief through Emerging and Accessible Therapy for PTSD TRICARE Act U.S. House of Representatives 2026-05-12 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I119th CONGRESS2d SessionH. R. 8764IN THE HOUSE OF REPRESENTATIVESMay 12, 2026Mr. Perry introduced the following bill; which was referred to the Committee on Armed ServicesA BILLTo direct the Secretary of Defense to furnish stellate ganglion block to members of the Armed Forces with post-traumatic stress disorder, and for other purposes.

1.

Short title

This Act may be cited as the Treatment and Relief through Emerging and Accessible Therapy for PTSD TRICARE Act or the TREAT PTSD TRICARE Act.

2.

Provision of stellate ganglion block to members of the Armed Forces with post-traumatic stress disorder

(a)

Provision to members of the Armed Forces

(1)

In general

Chapter 55 of title 10, United States Code, is amended by inserting after section 1074o the following new section:

1074p.

Provision of stellate ganglion block for certain members

(a)

In general

The Secretary shall furnish stellate ganglion block to any member of the Armed Forces (including the reserve components) who is performing or has performed active service and who— (1)is enrolled in the TRICARE program under chapter 55 of this title; (2)has been diagnosed with post-traumatic stress disorder; and (3)has elected to receive stellate ganglion block after being informed by a qualified health care provider of the risks and benefits of stellate ganglion block. (b)

Provision of care

The Secretary may furnish stellate ganglion block under subsection (a) through a medical facility of the Department or through a qualified health care provider participating in a Department administered TRICARE health insurance program.

. (2)

Clerical amendment

The table of contents at the beginning of chapter 55 of title 10, United States Code, is amended by inserting after the item relating to section 1074o the following new item: 1074p. Provision of stellate ganglion block for certain members.. (b)

Update of joint clinical practice guideline

(1)

Update of guideline

Not later than 180 days after the date of the enactment of this Act, the Secretary of Defense shall update the guideline titled the VA/DOD Clinical Practice Guideline (CPG) for the Management of PTSD (or such successor guideline) to ensure the guideline— (A)reflects the availability of stellate ganglion block as a therapy option; and (B)includes information on the clinical indicators and contraindicators for such therapy option. (2)

Notification

Upon updating the guideline under paragraph (1), the Secretary shall notify the congressional defense committees (as such term is defined in section 101 of title 10, United States Code) of such update. (c)

Effective date

The amendment made by subsection (a) shall take effect on the date that is 180 days after the date of the enactment of this Act.